Skip to headlines
clockwire Search
LIVE
Scientists built a drone that spins like a top to see in every direction, and it’s pretty genius OpenAI’s newest release lands to rough reviews Tyrone politician to repay money after backlash over spending €660 on office coffee machine Anthropic’s IPO asks investors to bet that a product can build a company, not the other way around Morocco Mobilizes 2.5 Billion Dirhams for Startups, Prepares Public AI Assistants Copper tumbles to seven-month low on speculative selling and inflation fears Why the Heat are wearing special 'Vice City' jerseys to promote GTAVI's release Officials correct not to dismiss Leeds' Jayden Bogle for tackle on Tottenham's Mathys Tel - KMI Panel Blue Badge holders must follow three rules or risk paying 'up to £1,000' TNL Mediagene regains Nasdaq equity compliance after subsidiary sale Einride AB reports Q3 results; reaffirms FY2026 outlook Amadou Onana signs new Aston Villa contract Hyperscale Data Series E Cumulative Redeemable Perpetual Preferred Stock declares $0.2083 dividend Target heads into crucial holiday season with strong third-quarter sales Grieving parents call for NHS changes as 20-second scan could have saved baby’s life
‹ Back to your news
Yicura BioMed eyes IPO as CEO says Hong Kong biotech scene needs more patient capital

MARKETS Hong Kong

Yicura BioMed eyes IPO as CEO says Hong Kong biotech scene needs more patient capital

Covered by 1 source First reported

How each outlet tells it

South China Morning Post (CN) · private

Yicura BioMed eyes IPO as CEO says Hong Kong biotech scene needs more patient capital

Yicura BioMed eyes IPO as CEO says Hong Kong biotech scene needs more patient capital

Hong Kong needs more “patient capital” and more talent capable of commercialising research and development to sustain the city’s biotechnology ecosystem, according to a senior executive at a…

Read at South China Morning Post